Does MDMA have treatment potential in sexual dysfunction? A systematic review of outcomes across the female and male sexual response cycles

Author:

Wexler Ava1,Dubinskaya Alexandra2,Suyama Julie34,Komisaruk Barry R5,Anger Jennifer67,Eilber Karyn8

Affiliation:

1. The Hebrew University- Hadassah Medical School , Jerusalem, 9112001 , Israel

2. Los Angeles Institute for Pelvic and Sexual Medicine , Beverly Hills, CA, 90210 , United States

3. Department of Obstetrics , Gynecology and Reproductive Sciences, , La Jolla, CA, 90213 , United States

4. University of California San Diego , Gynecology and Reproductive Sciences, , La Jolla, CA, 90213 , United States

5. Psychology Department, Rutgers University , Newark, NJ, 07102 , United States

6. Division of Gender Affirming Surgery , Urologic Reconstruction, and Female Pelvic Medicine, , La Jolla, CA, 92093 , United States

7. Department of Urology, University of California San Diego , Urologic Reconstruction, and Female Pelvic Medicine, , La Jolla, CA, 92093 , United States

8. Division of Urology, Department of Surgery, Cedars-Sinai Medical Center , Beverly Hills, 90048, CA , United States

Abstract

Abstract Introduction Sexual health, an integral component of overall well-being, is frequently compromised by common yet underdiagnosed sexual dysfunctions. Traditional interventions encompass pharmaceutical and psychological treatments. Unconventional therapies, like MDMA, offer hope for sexual dysfunction. This review delves into MDMA’s effects on sexual responsiveness and its potential role in treating sexual dysfunction. Objectives The purpose of this review is to elucidate effects of MDMA on different domains of the female and male sexual response cycles. Methods We conducted a systematic review on the effects of MDMA on each domain of the female and male sexual response cycles. PubMed, MEDLINE, and EMBASE were queried, and results were screened using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Search terms utilized were “MDMA” or “ecstasy” in combination with “desire,” “arousal,” “lubrication,” “orgasm,” “pleasure,” “libido,” “erection,” and “ejaculation.” Inclusion criteria for this review were MDMA use by study subjects and sexual outcomes in at least 1 domain of the female and/or male sexual response cycles were described and measured. Randomized controlled trials, cohort studies (both prospective and retrospective), surveys, and literature reviews published between January 2000 and June 2022 were included. Case reports and studies that did not address conditions of interest were excluded from analysis. Duplicated search results were screened out. The remaining studies were then read in full text to ensure they met inclusion and exclusion criteria for analysis. Results We identified 181 studies, of which 6 met criteria for assessment of the female sexual response cycle and 8 met criteria for assessment of the male sexual response cycle. Four of 6 studies reported increased sexual desire with MDMA use among women. Arousal and lubrication were improved with MDMA use in 3 of 4 studies, but they were not affected in 1 randomized control study. In men, 7 studies evaluated the effects of MDMA on desire and/or arousal, 5 studies measured impact on erection, 3 on orgasm, and 2 on ejaculation. Sixty percent of interview-based studies reported increased sexual desire in men, while 40% reported mixed or no effect. Two studies reported impairment of erection, 2 reported mixed effects, and 1 reported fear of erection impairment. In both men and women, all studies evaluating orgasm reported delay in achieving orgasm but increased intensity and pleasure if achieved. Primary outcome measures were variable and largely qualitative. Conclusion Our findings suggest that MDMA generally increases sexual desire and intensifies orgasm when achieved. While producing conflicting evidence on sexual arousal in both sexes, MDMA may impair erectile and ejaculatory function in men.

Publisher

Oxford University Press (OUP)

Subject

Urology,Obstetrics and Gynecology,Reproductive Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Psychiatry and Mental health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3